FDA Adverse Event Other Summary report: N

RADIESSE DERMAL FILLER

MDR report key: 3628080 · Received February 7, 2014

Report

Report Number
2135225-2014-00002
Event Type
Other
Date Received
February 7, 2014
Date of Event
January 9, 2014
Report Date
January 10, 2014
Manufacturer
MERZ NORTH AMERICAL, INC.
Product Code
LMH
PMA / PMN Number
P050052
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN ASSISTANT

Narratives

Additional Manufacturer Narrative · 1

(B)(4). (B)(6) SPOKE TO A (B)(6) PHYSICIAN, DR. (B)(4). DR. (B)(4) STATED THAT THIS IS A CASE OF VASCULAR COMPROMISE. THE DEVICE HISTORY RECORD FOR REPORTED RADIESSE LOT WAS REVIEWED. ALL REQUIRED TESTING SPECIFICATIONS FOR THIS LOT WERE MET PRIOR TO RELEASE. NO NON-CONFORMANCES WERE DISCOVERED THAT WOULD HAVE CONTRIBUTED TO THIS EVENT.

Description of Event or Problem · 1

ON (B)(6) 2014, (B)(6) CALLED (B)(4) TO REPORT THAT SHE INJECTED A FEMALE PATIENT ON (B)(6) 2014. (B)(6) INJECTED 0.1CC RADIESSE INTO THE GLABELLA AND 0.1CC INJECTED INTO THE PERIOSTEAL AREA. INJECTED AREA WAS GREEN. INJECTOR THOUGHT SHE GOT A VESSEL. SHE USED PRESSURE AND RUBBED AROUND. THE AREA WAS GREEN WHEN THE PATIENT LEFT. (B)(6) THOUGHT THAT THE PATIENT WOULD END UP WITH A BRUISE. THE PATIENT CALLED (B)(6) AT 7AM ON (B)(6) 2014, (B)(6) INSTRUCTED THE PATIENT TO GO TO THE ER. (B)(6) PROVIDED A NOTE FOR THE PATIENT TO TAKE TO THE ER ABOUT USING WARM COMPRESS, ETC. A CT SCAN WAS PERFORMED. THERE WAS PRODUCT IN A VESSEL. THE PATIENT'S VISION WAS CHECKED AND PER THE PATIENT HER VISION IS OK. THERE WAS NO BLANCHING AT THE TIME OF THE INJECTION. THERE IS NO TISSUE DEATH AND IT HAS BEEN OVER 12 HOURS SINCE THE INJECTION. (B)(6) HAS INVOLVED HER MEDICAL DIRECTOR WHO IS A P.S. THEY ARE GOING TO TRY TO GET THE PATIENT TO COME BACK IN ON EITHER (B)(6) 2014 OR (B)(6) 2014.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
80971 RADIESSE DERMAL FILLER INJECTABLE IMPLANT LMH MERZ NORTH AMERICAL, INC. 100068836

Patients

Seq Age Sex Outcome Treatment
1 UNK Required Intervention